Abbonarsi

Tape-strip profiling identifies unique immune and lipid dysregulation in patients with seborrheic dermatitis - 19/05/25

Doi : 10.1016/j.jaad.2025.01.082 
Benjamin Ungar, MD a, Meredith Manson, BA a, Madeline Kim, MD, MS a, Digpal Gour, PhD a, Panipak Temboonnark, MD a, Ragasruti Metukuru, MSc a, Joel Correa Da Rosa, PhD a, Yeriel Estrada, BS a, Jesús Gay-Mimbrera, PhD b, Pedro J. Gómez-Arias, MD b, Juan Ruano, MD, PhD b, Avner Shemer, MD c, Diane Hanna, DNP d, Patrick Burnett, MD, PhD d, Emma Guttman-Yassky, MD, PhD a,
a Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York 
b Department of Dermatology, IMIBIC/Reina Sofía University Hospital/University of Cordoba, Córdoba, Spain 
c Department of Dermatology, Sheba Medical Center, Ramat-Gan, Israel 
d Arcutis Biotherapeutics, Inc., Westlake Village, California 

Correspondence to: Emma Guttman-Yassky, MD, PhD, The Kimberly and Eric J. Waldman Department of Dermatology, Laboratory of Inflammatory Skin Diseases, Icahn School of Medicine at Mount Sinai, 1425 Madison Ave, Box 1047, New York, NY 10029-6574. The Kimberly and Eric J. Waldman Department of Dermatology Laboratory of Inflammatory Skin Diseases Icahn School of Medicine at Mount Sinai 1425 Madison Ave Box 1047 New York NY 10029-6574

Abstract

Background

Seborrheic dermatitis (SD) is a common, chronic inflammatory skin disease with limited understanding of its pathophysiology. Molecular profiling has been limited by invasiveness of sampling methods.

Objective

To analyze the molecular skin profile of adult patients with SD using tape strips.

Methods

Tape-strips obtained from facial lesions of 26 adult SD patients and 18 demographically matched healthy controls were evaluated with RNA sequencing.

Results

SD molecular skin fingerprint was characterized by strong and significant upregulation of interleukin (IL)23/T-helper (Th)17 and Th22 (i.e. IL23A, IL22, PI3, LL37, S100A8, S100A12), some Th1 skewing (OASL, STAT1, CXCL9), and limited Th2 modulation. A parallel downregulation of barrier markers (CLDN1/8, FA2H, ELOVL3) was also observed.

Limitations

Limited representation of mild and severe SD patients.

Conclusion

These data deepen our understanding of SD suggesting that it has robust Th17/Th22, some Th1 skewing, and minimal Th2 activation, and associated skin barrier alterations. This provides rationale for novel immunomodulatory treatment approaches for SD patients targeting IL23/Th17 and/or Th22 pathways.

Il testo completo di questo articolo è disponibile in PDF.

Key words : atopic dermatitis, face, facial, IL-17, IL-23, IL-36, profiling, psoriasis, seb derm, seborrheic dermatitis, tape strip, tape-strip, tape-stripping, Th17, Th22, transcriptomic

Abbreviations used : AD, BC, DEG, FCH, FDA, FDR, GSVA, HC, IGA, IL, PSO, SD, Th


Mappa


  Funding sources: Funding for this study was provided by Arcutis Biotherapeutics, Inc . This work was also supported by the Icahn School of Medicine Clinical Translational Science Award ( UL1TR004419 ) TL-1 program.
 Patient consent: The authors attest to obtaining written patient consent for the publication of recognizable patient photographs or other identifiable material, with the understanding that this information may be publicly available.
 IRB approval status: Reviewed and approved by the institutional review board of the Icahn School of Medicine at Mount Sinai.


© 2025  The Author(s). Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 92 - N° 6

P. 1277-1287 - giugno 2025 Ritorno al numero
Articolo precedente Articolo precedente
  • An international multicenter, retrospective cohort study of 203 patients with pediatric androgenetic alopecia
  • Tyan Shin Lee, Mara O'Connor, Leslie Castelo-Soccio, Dawn Eichenfield, Danny Lee, Amy S. Paller, Manuel Valdebran, Jenna Vroman, Angela Yang, Grace L. Lee, Megan Craddock, Cathryn Sibbald
| Articolo seguente Articolo seguente
  • Same-day human papilloma virus vaccination improves vaccine uptake in a dermatology sexually transmitted infection clinic: A quality improvement-based model for improving vaccination rates
  • Jaclyn Rosenthal Himeles, Costner McKenzie, Sophia Manduca, Katharina S. Shaw, Zina Jones, Arielle Nagler, Miriam Keltz Pomeranz, Daniel Gutierrez, John G. Zampella

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.